Cause-specific mortality of low and selective intermediate-risk prostate cancer patients with active surveillance or watchful waiting

por Wu, Xiangkun, Lv, Daojun, Eftekhar, Md, Cai, Chao, Zhao, Zhijian, Gu, Di, Liu, Yongda
Publicado 2021

A 10-gene signature as a predictor of biochemical recurrence after radical prostatectomy in patients with prostate cancer and a Gleason score ≥7

por Wu, Xiangkun, Lv, Daojun, Lei, Ming, Cai, Chao, Zhao, Zhijian, Eftekhar, Md, Gu, Di, Liu, Yongda
Publicado 2020

A new risk stratification system of prostate cancer to identify high-risk biochemical recurrence patients

por Wu, Xiangkun, Lv, Daojun, Eftekhar, Md, Khan, Aisha, Cai, Chao, Zhao, Zhijian, Gu, Di, Liu, Yongda
Publicado 2020

Safety and Efficacy Study of Neoadjuvant Radiohormonal Therapy for Oligometastatic Prostate Cancer: Protocol of an Open-Label, Dose-Escalation, Single-Centre Phase I/II Clinical Tr...

por Zhao, Xianzhi, Xiao, Yu-Tian, Yang, Yue, Ye, Yusheng, Chang, Yifan, Jiang, Lingong, Eftekhar, Md, Ren, Shancheng, Zhang, Huojun
Publicado 2022